Avantor Inc. Company Profile
NYSE: AVTRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 10:11 AM ET
Avantor at a glance
Avantor Inc. (NYSE: AVTR) is a Biotechnology: Laboratory Analytical Instruments company in the Industrials sector headquartered in Radnor, PA. Avantor is led by Mr. Emmanuel Ligner and employs about 13,500 people. The company's shares have traded publicly since 2019.
At a market capitalization of $10.44 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001722482, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Avantor do?
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- Avantor Inc.
- Ticker
- NYSE: AVTR
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Mr. Emmanuel Ligner
- Employees
- 13,500
- Headquarters
- Radnor Corporate Center, Radnor, PA, United States
- Phone
- 610 386 1700
- Website
- avantorsciences.com
- IPO year
- 2019
- Market cap
- $10.44B
- SEC CIK
- 0001722482
- Latest annual report
- 10-K · Feb 11, 2026
Companies similar to Avantor
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BIOBio-Rad Laboratories Inc. Class A | 358.90 | -2.45% | $9.60B | vs AVTR |
| TXG10x Genomics Inc. Class A | 73.45 | -3.48% | $9.57B | vs AVTR |
| BRKRBruker Corporation | 57.09 | -4.40% | $8.70B | vs AVTR |
| RVTYRevvity Inc. | 147.55 | -3.94% | $16.46B | vs AVTR |
| ALMRAlamar Biosciences Inc. | 25.82 | -7.04% | $1.79B | vs AVTR |
| PACBPacific Biosciences of California Inc. | 2.50 | -8.27% | $775.52M | vs AVTR |
| CTKBCytek Biosciences Inc. | 5.14 | -3.84% | $667.46M | vs AVTR |
| EYPTEyePoint Inc. | 3.34 | +0.60% | $280.03M | vs AVTR |